查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225300

中樞神經系統 (CNS) 治療市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

Central Nervous System (CNS) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2022 年，全球中樞神經系統 (CNS) 治療藥物市場將達到 1312 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 2146 億美元，顯示 2023 年至 2028 年之間的增長率 (CAGR) 為 6.8%。

中樞神經系統 (CNS) 是指由大腦和脊髓組成的神經系統的重要部分。 中樞神經系統對接收到的信息進行整合，協調和控制全身各部分的活動。 中樞神經系統治療劑主要有麻醉藥、抗驚厥藥、中樞神經興奮藥、肌肉鬆弛藥、麻醉鎮痛藥、鎮靜藥等。 它們廣泛用於帕金森病、抑鬱症、阿爾茨海默病、癲癇、創傷性腦損傷、脊髓損傷、中樞神經系統癌症等的治療過程。

中樞神經系統 (CNS) 藥物的市場趨勢

  • 精神疾病和與生活方式相關的中樞神經系統疾病（例如焦慮、抑鬱和高血壓）的患病率上升是推動全球中樞神經系統治療市場發展的主要動力。 全球市場也受到越來越多易患慢性神經系統疾病（如阿爾茨海默病和帕金森病）的老年人口的推動。 此外，負擔得起的仿製藥在新興市場越來越受歡迎，這進一步擴大了 CNS 治療藥物的市場。 除此之外，中樞神經系統治療程序的不斷創新，如基因治療、神經刺激工具和神經移植技術的發展，也在推動市場增長。 這些方法延長了持續多巴胺能興奮劑的作用並控制了疾病進展。 此外，新型藥物輸送系統的推出提供了易於管理和各種劑型的可用性，為全球 CNS 市場創造了更加光明的前景。 例如，透皮貼劑在神經病學領域因治療中樞神經系統疾病而受到歡迎，因為它們可以提供精確數量的藥物並提供長達 24 小時的緩解。 除此之外，政府和非政府組織對提高對許多中樞神經系統疾病的認識以及增加獲得多種治療選擇的機會的關注也是市場增長的催化劑。 此外，支持加速批准神經退行性疾□□病管道藥物的有利指南的啟動和促進新產品進入的臨床試驗預計將在未來幾年推動全球中樞神經系統治療市場。

主要市場細分

  • IMARC Group 對全球中樞神經系統 (CNS) 治療市場報告的每個子細分市場的主要趨勢進行了分析，並預測了 2023 年至 2028 年在全球、區域和國家層面的增長。 該報告根據疾病和應用對市場進行分類。

按疾病分類

  • 神經退行性疾□□病
  • 阿爾茨海默氏癡呆症
  • 帕金森病
  • 多發性硬化症
  • 亨廷頓舞蹈症
  • 肌萎縮側索硬化症
  • 其他
  • 神經血管疾病
  • 中樞神經系統創傷
  • 心理健康
  • 焦慮症
  • 癲癇症
  • 情緒障礙
  • 精神疾病
  • 其他
  • 感染
  • 中樞神經系統癌症
  • 其他

按應用細分

  • 醫院
  • 診所
  • 家庭護理
  • 其他

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

內容

第一章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據來源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第四章介紹

  • 概覽
  • 主要行業趨勢

第 5 章全球中樞神經系統 (CNS) 藥物市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按疾病劃分的市場細分

  • 神經退行性疾□□病
    • 市場趨勢
    • 主要細分市場
      • 阿爾茨海默氏癡呆症
      • 帕金森病
      • 多發性硬化症
      • 亨廷頓舞蹈症
      • 肌萎縮側索硬化症
      • 其他
    • 市場預測
  • 神經血管疾病
    • 市場趨勢
    • 市場預測
  • 中樞神經系統創傷
    • 市場趨勢
    • 市場預測
  • 心理健康
    • 市場趨勢
    • 主要細分市場
      • 焦慮症
      • 癲癇症
      • 情緒障礙
      • 精神疾病
      • 其他
    • 市場預測
  • 感染
    • 市場趨勢
    • 市場預測
  • 中樞神經系統癌症
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章應用市場細分

  • 醫院
    • 市場趨勢
    • 市場預測
  • 醫務室
    • 市場趨勢
    • 市場預測
  • 家庭護理
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第9章SWOT分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第 10 章價值鏈分析

第11章波特五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • AstraZeneca plc
    • Biogen Inc.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG（Roche Holding）
    • H. Lundbeck A/S
    • Merck & Co. Inc.
    • Neurocrine Biosciences Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR1423A141_Report

The global central nervous system (CNS) therapeutics market size reached US$ 131.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 214.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.

The central nervous system (CNS) represents a vital part of the nervous system that comprises of the brain and the spinal cord. It integrates the received information, thereafter coordinating and controlling the activities of all parts of the body. CNS therapeutics primarily include anesthetics, anticonvulsants, CNS stimulants, muscle relaxants, narcotic analgesics, sedatives, etc. They are widely adopted in the treatment procedures of Parkinson's disease, depression, Alzheimer's disease, epilepsy, traumatic brain, spinal cord injury, CNS cancer, etc.

Central Nervous System (CNS) Therapeutics Market Trends:

  • The elevating prevalence of mental illness and lifestyle-associated CNS disorders, including anxiety, depression, hypertension, etc., is primarily driving the global CNS therapeutics market. In line with this, the growing geriatric population, who are more prone to chronic neurological ailments such as Alzheimer's disease and Parkinson's disease, is also propelling the global market. Additionally, the emerging popularity of generic neurologic drugs across developing countries on account of their affordability is further augmenting the market for CNS therapeutics. Apart from this, continuous innovations in CNS treatment procedures, such as the development of gene therapy, neurostimulation tools, and neural transplantation techniques, are also stimulating the market growth. These approaches prolong the action of unremitting dopaminergic stimulation medicines and control disease progression. Moreover, the introduction of novel drug-delivery systems that provide ease of administration and availability of different dosage forms is further creating a positive outlook for the global CNS market. For instance, transdermal patches are gaining traction in the field of neurology to treat CNS disorders as they offer a precise amount of medicine and relief for around 24 hours. Besides this, the increasing focus of the government and non-government organizations on creating awareness regarding numerous CNS disorders and the accessibility to multiple treatment options is also catalyzing the market growth. Moreover, the launch of favorable guidelines to support faster approvals of pipeline drugs for neurodegenerative diseases and clinical trials that encourage the entry of new products is expected to drive the global central nervous system therapeutics market in the coming years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global central nervous system (CNS) therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease and application.

Breakup by Disease:

  • Neurodegenerative Diseases
  • Alzheimer's Disease
  • Parkinson's Disease
  • Multiple Sclerosis
  • Huntington's Disease
  • Amyotrophic Lateral Sclerosis
  • Others
  • Neurovascular Diseases
  • CNS Trauma
  • Mental Health
  • Anxiety Disorders
  • Epilepsy
  • Mood Disorders
  • Psychotic Disorders
  • Others
  • Infectious Diseases
  • CNS Cancer
  • Others

Breakup by Application:

  • Hospital
  • Clinic
  • Homecare
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding), H. Lundbeck A/S, Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
  • Key Questions Answered in This Report
  • 1. What was the size of the global Central Nervous System (CNS) therapeutics market in 2022?
  • 2. What is the expected growth rate of the global Central Nervous System (CNS) therapeutics market during 2023-2028
  • 3. What are the key factors driving the global Central Nervous System (CNS) therapeutics market?
  • 4. What has been the impact of COVID-19 on the global Central Nervous System (CNS) therapeutics market?
  • 5. What is the breakup of the global Central Nervous System (CNS) therapeutics market based on the disease?
  • 6. What are the key regions in the global Central Nervous System (CNS) therapeutics market?
  • 7. Who are the key players/companies in the global Central Nervous System (CNS) therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Central Nervous System (CNS) Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease

  • 6.1 Neurodegenerative Diseases
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Alzheimer's Disease
      • 6.1.2.2 Parkinson's Disease
      • 6.1.2.3 Multiple Sclerosis
      • 6.1.2.4 Huntington's Disease
      • 6.1.2.5 Amyotrophic Lateral Sclerosis
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Neurovascular Diseases
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CNS Trauma
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Mental Health
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Anxiety Disorders
      • 6.4.2.2 Epilepsy
      • 6.4.2.3 Mood Disorders
      • 6.4.2.4 Psychotic Disorders
      • 6.4.2.5 Others
    • 6.4.3 Market Forecast
  • 6.5 Infectious Diseases
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 CNS Cancer
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospital
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Homecare
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AstraZeneca plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biogen Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Eli Lilly and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 F. Hoffmann-La Roche AG (Roche Holding)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 SWOT Analysis
    • 13.3.5 H. Lundbeck A/S
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Merck & Co. Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Neurocrine Biosciences Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Pfizer Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sanofi S.A.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Takeda Pharmaceutical Company Limited
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Teva Pharmaceutical Industries Ltd.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Central Nervous System Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Central Nervous System Therapeutics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Central Nervous System Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Central Nervous System Therapeutics Market: Breakup by Disease (in %), 2022
  • Figure 5: Global: Central Nervous System Therapeutics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Central Nervous System Therapeutics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Central Nervous System Therapeutics (CNS Trauma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Central Nervous System Therapeutics (CNS Trauma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Central Nervous System Therapeutics (Mental Health) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Central Nervous System Therapeutics (Mental Health) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Central Nervous System Therapeutics (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Central Nervous System Therapeutics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Central Nervous System Therapeutics (CNS Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Central Nervous System Therapeutics (CNS Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Central Nervous System Therapeutics (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Central Nervous System Therapeutics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Central Nervous System Therapeutics (Hospital) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Central Nervous System Therapeutics (Hospital) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Central Nervous System Therapeutics (Clinic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Central Nervous System Therapeutics (Clinic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Central Nervous System Therapeutics (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Central Nervous System Therapeutics (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Central Nervous System Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Central Nervous System Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: North America: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: North America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: United States: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: United States: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Canada: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Canada: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Asia-Pacific: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Asia-Pacific: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: China: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: China: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Japan: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Japan: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: India: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: India: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: South Korea: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: South Korea: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Australia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Australia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Indonesia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Indonesia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Europe: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Europe: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Germany: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Germany: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: France: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: France: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United Kingdom: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United Kingdom: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Italy: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Italy: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Spain: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Spain: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Russia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Russia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Latin America: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Latin America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Brazil: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Brazil: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Mexico: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Mexico: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Middle East and Africa: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Middle East and Africa: Central Nervous System Therapeutics Market: Breakup by Country (in %), 2022
  • Figure 77: Middle East and Africa: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Global: Central Nervous System Therapeutics Industry: SWOT Analysis
  • Figure 79: Global: Central Nervous System Therapeutics Industry: Value Chain Analysis
  • Figure 80: Global: Central Nervous System Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Central Nervous System Therapeutics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Disease (in Million US$), 2023-2028
  • Table 3: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Central Nervous System Therapeutics Market: Competitive Structure
  • Table 6: Global: Central Nervous System Therapeutics Market: Key Players